Metastasis Models

Contact Us

Metastatic disease accounts for the majority of cancer-related mortalities. The genes and proteins involved in metastasis have long been sought after as potential therapeutic targets. Our tumor portfolio contains a number of proprietary, efficient and reproducible metastasis models.

CTPET, and optical imaging technologies provide rapid, non-invasive, highly efficient, and accurate determination of drug response in these models. In particular bioluminescence imaging, through the use of luciferase-enabled tumor lines, is a highly efficient method for tracking metastatic disease. The metastasis models we use are evaluated for reproducible growth characteristics in vivo and are available for both preventative and staged-treatment testing.

In order to establish metastasis models, varying types of transmission modes include:

  • Spontaneous metastasis from implanted solid tumors

  • Intracardiac cell injection

  • Intravenous cell injection

  • Intrasplenic cell injection

  • Peritibial implantation

We continually develop and optimize new metastasis models.

Molecule 3d rendering


The Model Makes All the Difference

Our scientists work collaboratively with you to thoroughly evaluate your drug candidates, planning an approach that takes advantage of the widest breadth of analysis tools and models in the industry. Use our cell line models to interrogate the pharmacology of your drug candidates and get the decision-driving data you need to make go/no-go decisions on drugs in your preclinical oncology pipeline.


Let's start a conversation

Contact Us